A Recent Tax Ruling Has Made ANDA Litigation Less Burdensome for Generics
In Actavis v. U.S., a case at the intersection of tax law and patent law, the Federal Circuit held that generic drug companies’...
A Recent Tax Ruling Has Made ANDA Litigation Less Burdensome for Generics
In Actavis v. U.S., a case at the intersection of tax law and patent law, the Federal Circuit held that generic drug companies’...